Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.77234 | 63 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.54438 | 59 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.53969 | 59 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.50808 | 59 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.52744 | 60 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.73906 | 61 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.54106 | 57 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.52861 | 59 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.68971 | 62 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.44419 | 57 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.59131 | 60 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.53288 | 59 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.53528 | 59 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.50428 | 58 |